ISSN: 2278-0238

薬学および生命科学における研究開発の国際ジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

The Role of Validations and Quality Management systems Related Regulatory observations in the Global Pharmaceutical sector

Dr. Sagaram Sudhakar

It is very essential to reflect upon the fact that validation activities play a very important and critical role in the Pharmaceutical manufacturing sector. During the project execution the organization should pay a close attention for these activities. And there must be a Risk assessment and risk mitigation program. The Documentation of these activities must be Designed and executed properly. The review of the recent regulatory observations shows that there is a big gap in this regard which leads to the issue of the 483 observations.

Once again it is very interesting to reflect upon the fact that the number. In the GMP warning letters were increased In this presentation we are going to focus on the trends of the warning letters issued in 2018-19 and the trend of the 483 issued by the regulatory authorities.

It is very essential to reflect upon the fact that Documentation activities play a very important and play critical role in the Global Pharmaceutical manufacturing sector. Designee and execution of procedure is possible only thorough Good documentation Practice only During the Regulatory audits the presentation of Documentation roll is very critical and the organization should pay a close attention for these activities. And there must be a Risk assessment and risk mitigation program. The Documentation of these activities must be designed and executed properly.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません。